UA74012U - Способ профилактики гнойных осложнений онкопластических операций - Google Patents
Способ профилактики гнойных осложнений онкопластических операций Download PDFInfo
- Publication number
- UA74012U UA74012U UAU201204783U UAU201204783U UA74012U UA 74012 U UA74012 U UA 74012U UA U201204783 U UAU201204783 U UA U201204783U UA U201204783 U UAU201204783 U UA U201204783U UA 74012 U UA74012 U UA 74012U
- Authority
- UA
- Ukraine
- Prior art keywords
- preventing
- tumor
- oncological
- complications
- surgery
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 13
- 230000000771 oncological effect Effects 0.000 title abstract 2
- 238000002278 reconstructive surgery Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 14
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 10
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 10
- 238000001356 surgical procedure Methods 0.000 claims abstract description 9
- 229940124350 antibacterial drug Drugs 0.000 claims abstract description 4
- 208000025865 Ulcer Diseases 0.000 claims description 10
- 231100000397 ulcer Toxicity 0.000 claims description 9
- 230000000813 microbial effect Effects 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims description 2
- LKJCZXIGFPOQPC-UHFFFAOYSA-N SSSSSSSSSSSSSSSS Chemical compound SSSSSSSSSSSSSSSS LKJCZXIGFPOQPC-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 201000000849 skin cancer Diseases 0.000 description 4
- 230000017105 transposition Effects 0.000 description 4
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000002316 cosmetic surgery Methods 0.000 description 3
- 229960003722 doxycycline Drugs 0.000 description 3
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 229960004755 ceftriaxone Drugs 0.000 description 2
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 2
- 229940106164 cephalexin Drugs 0.000 description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 2
- 229960003405 ciprofloxacin Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 229960003907 linezolid Drugs 0.000 description 2
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 210000003455 parietal bone Anatomy 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010065152 Coagulase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000003583 cytomorphological effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
Landscapes
- Prostheses (AREA)
Abstract
Способ профилактики гнойных осложнений онкопластических операций включает назначение антибиотиков в день хирургического вмешательства, определение микробного спектра с изъязвленной поверхности опухоли, назначение таргетных антибактериальных препаратов.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201204783U UA74012U (ru) | 2012-04-17 | 2012-04-17 | Способ профилактики гнойных осложнений онкопластических операций |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201204783U UA74012U (ru) | 2012-04-17 | 2012-04-17 | Способ профилактики гнойных осложнений онкопластических операций |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA74012U true UA74012U (ru) | 2012-10-10 |
Family
ID=50851370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201204783U UA74012U (ru) | 2012-04-17 | 2012-04-17 | Способ профилактики гнойных осложнений онкопластических операций |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA74012U (ru) |
-
2012
- 2012-04-17 UA UAU201204783U patent/UA74012U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anandi et al. | Bacteriology of diabetic foot lesions | |
| Banche et al. | Microbial adherence on various intraoral suture materials in patients undergoing dental surgery | |
| Mendonca et al. | Negative‐pressure wound therapy: a snapshot of the evidence | |
| Lund-Nielsen et al. | Qualitative bacteriology in malignant wounds—a prospective, randomized, clinical study to compare the effect of honey and silver dressings | |
| Curi et al. | Opportunistic actinomycosis in osteoradionecrosis of the jaws in patients affected by head and neck cancer: incidence and clinical significance | |
| Biffi et al. | Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver | |
| Kulichová et al. | Surgical site infections in skin surgery: a single center experience | |
| Chen et al. | Do antibacterial-coated sutures reduce wound infection in head and neck cancer reconstruction? | |
| Varga et al. | Neglected basal cell carcinomas in the 21st century | |
| Chen et al. | Vacuum-assisted closure combined with a closed suction irrigation system for treating postoperative wound infections following posterior spinal internal fixation | |
| Dowsett | Using the TIME framework in wound bed preparation | |
| Sasikumar et al. | Clinico-microbiological profile of septic diabetic foot with special reference to anaerobic infection | |
| Moreno‐Arias et al. | Second intention healing after Mohs micrographic surgery | |
| Grekova et al. | The effects of topical application of metronidazole for treatment of chronic anal fissure: A randomized, controlled pilot study | |
| Nakamura et al. | Invasive and in situ lesions of squamous cell carcinoma are independent factors for postoperative surgical‐site infection after outpatient skin tumors surgery: a retrospective study of 512 patients | |
| Simões et al. | Antimicrobial photodynamic therapy on treatment of infected radiation-induced oral mucositis: Report of two cases | |
| UA74012U (ru) | Способ профилактики гнойных осложнений онкопластических операций | |
| Gupta et al. | Marjolin’s ulcer of the scalp invading calvarial bone, dura and brain | |
| Hohl et al. | Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin | |
| Sravanti et al. | A case of bilateral injection abscesses caused by Graphium type of Scedosporium apiospermum | |
| Molska et al. | Microbiology of breast tissue expanders | |
| Valerón-Almazán et al. | Extensive, non-healing scalp ulcer associated with trauma-induced chronic osteomyelitis | |
| Lloyd et al. | Conservative treatment of osteoradionecrosis of the cranium after treatment of cutaneous malignancy with mohs surgery and postoperative radiation | |
| Shaw et al. | Otolaryngologic community-acquired MRSA infections in a suburban private practice | |
| Harding | Wound infection: Managing wound infection |